Peptides from lactobacillus hydrolysates of bovine milk caseins inhibit prolyl-peptidases of human colon cells

Journal of Agricultural and Food Chemistry

Volumn 59, Issue 1, 2011, Pages 370-377

  Juillerat Jeanneret, Lucienne ^a   Robert, Marie Claude ^b   Juillerat, Marcel A ^b  

^a UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

Casein peptides; dipeptidyl prolyl amino peptidases; human colon cells; matrix metalloproteinases; prolyl oligopeptidases

Indexed keywords

ANGIOTENSIN-CONVERTING ENZYME; BOVINE MILK; CYTOTOXIC; CYTOTOXIC EFFECTS; DIPEPTIDYL PROLYL-AMINO-PEPTIDASES; ENZYMATIC ACTIVITIES; HUMAN COLON; HUMAN COLON CELLS; HUMAN DIGESTIVE TRACT; INTACT CELLS; MATRIX METALLOPROTEASE; MATRIX METALLOPROTEINASES; OLIGOPEPTIDASES; PROTEOLYTIC ACTIVITIES; SELECTIVE INHIBITORS; SEQUENCE-DEPENDENT;

AMINO ACIDS; CASEIN; DIGESTIVE SYSTEM; ENZYME ACTIVITY; ENZYME INHIBITION; HYDROLASES;

PEPTIDES;

CASEIN; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PEPTIDE;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CATTLE; CHEMISTRY; COLON TUMOR; DOWN REGULATION; ENZYMOLOGY; HUMAN; LACTOBACILLUS; METABOLISM; MICROBIOLOGY; MILK; MOLECULAR GENETICS; TUMOR CELL LINE;

AMINO ACID SEQUENCE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CASEINS; CATTLE; CELL LINE, TUMOR; COLONIC NEOPLASMS; DOWN-REGULATION; HUMANS; LACTOBACILLUS; MILK; MOLECULAR SEQUENCE DATA; PEPTIDES; PEPTIDYL-DIPEPTIDASE A;

BOVINAE; LACTOBACILLUS;

EID: 78651073636     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf102803a     Document Type: Article

References (49)

1. Pender, S. L. F.; MacDonald, T. T. Matrix metalloproteinases and the gut - new roles for old enzymes. Curr. Opin. Pharmacol. 2004, 4, 546 - 550.
2. Gao, Q.; Meijer, M. J. W.; Kubben, F. J. G. M.; Sier, C. F. M.; Kruidenier, L.; van Dujin, W.; van den Berg, M.; van Hogezand, R. A.; Lamers, C. B. H. W.; Verspaget, H. W. Expression of matrix metalloproteinases-2 and -9 in intestinal tissue of patients with inflammatory bowel diseases. Digest. Liver Dis. 2005, 37, 584 - 592.
3. Xiao, Q.; Boushey, R. P.; Cino, M.; Drucker, D. J.; Brubaker, P. L. Circulating levels of glucagons-like peptide-2 in human subjects with inflammatory bowel disease Am. J. Physiol. 2000, 278, 1057-1063
4. Hildebrandt, M.; Rose, M.; Rüter, J.; Salama, A.; Mönnikes, H.; Klapp, B. F. Dipeptidyl peptidase IV (DP IV, CD26) in patients with inflammatory bowel disease Scand. J. Gastroenterol. 2001, 10, 1067-1072
5. Heymann, E.; Mentlein, R. Complementary action of dipeptidyl peptidase IV and aminopeptidase M in the digestion of β-casein J. Dairy Res. 1986, 53, 229-236
6. S2- casein FEBS Lett. 2002, 531, 369-374
7. Polgar, L. The prolyl oligopeptidase family Cell. Mol. Life Sci. 2002, 59, 349-362
8. Rosenblum, J. S.; Kosarich, J. W. Prolyl peptidases: a serine protease subfamily with high potential in drug discovery. Curr. Opin. Chem. Biol. 2003, 7, 496 - 504.
9. Weber, A. E. Dipeptidyl peptidase IV inhibitors for the treatment of diabetes J. Med. Chem. 2004, 47, 4135-4141
10. Juillerat-Jeanneret, L. Prolyl-specific peptidases and their inhibitors in biological processes Curr. Chem. Biol. 2008, 2, 97-109
11. Juillerat-Jeanneret, L.; Gerber-Lemaire, S. The prolyl-aminodipeptidases and their inhibitors as therapeutic targets for fibrogenic disorders Mini-Rev. Med. Chem. 2009, 9, 215-226
12. Lawandi, J.; Gerber-Lemaire, S.; Juillerat-Jeanneret, L.; Moitessier, N. Inhibitors of prolyl-oligopeptidases for the therapy of human diseases: defining diseases and inhibitors J. Med. Chem. 2010, 53, 3423-3438
13. Robert, M. C.; Razaname, A.; Mutter, M.; Juillerat, M. A. Identification of angiotensin-1-converting enzymes inhibitorypeptides derived from sodium caseinate hydrolysates produced by Lactobacillus helveticus NCC2765 J. Agric. Food Chem. 2004, 52, 6923-6931
14. Hosono, A.; Kashina, T.; Kada, T. Antimutagenic properties of lactic acid-cultured milk on chemical and fecal mutagens J. Dairy Sci. 1986, 69, 2237-2242
15. Brady, L. J.; Gallaher, D. D.; Busta, F. F. The role of probiotic cultures in the prevention of colon cancer J. Nutr. 2000, 130, 410S-414S
16. Knasmuller, S.; Steinkellner, H.; Hirschl, A. M.; Rabot, S.; Nobis, E. C.; Kassie, F. Impact of bacteria in dairy products and of the intestinal microflora on the genotoxic and carcinogenic effects of heterocyclic aromatic amines Mutat. Res. 2001, 480-481, 129-138
17. Oliveira, M. J.; Van Damme, J.; Lauwaet, T.; De, C. V.; De Bruyne, G.; Verschraegen, G.; Vaneechoutte, M.; Goethals, M.; Ahmadian, M. R.; Muller, O.; Vandekerckhove, J.; Mareel, M.; Leroy, A. β-Casein-derived peptides, produced by bacteria, stimulate cancer cell invasion and motility EMBO J. 2003, 22, 6161-6173
18. Perdigon, G.; Valdez, J. C.; Rachid, M. Antitumour activity of yogurt: study of possible immune mechanisms J. Dairy Res. 1998, 65, 129-138
19. Basset, P.; Okada, A.; Chenard, M. P.; Kannan, R.; Stoll, I.; Anglard, P.; Bellocq, J. P.; Rio, M. C. Matrix metalloproteinases as stromal effectors of human carcinoma progression: therapeutic implications Matrix Biol. 1997, 15, 535-541
20. Mook, O. R.; Frederiks, W. M.; Van Noorden, C. J. The role of gelatinases in colorectal progression and metastasis Biochim. Biophys. Acta 2004, 1705, 69-89
21. Hargrove, R. E.; Alford, J. A. Growth response of weanling rats to heated, aged, fractionated, and chemically treated yogurts J. Dairy Sci. 1980, 63, 1065-1072
22. Nadathur, S. R.; Gould, S. J.; Bakalinsky, A. T. Antimutagenicity of an acetone extract of yogurt Mutat. Res. 1995, 334, 213-224
23. Bakalinsky, A. T.; Nadathur, S. R.; Carney, J. R.; Gould, S. J. Antimutagenicity of yogurt Mutat. Res. 1996, 350, 199-200
24. Ganjam, L. S.; Thornton, W. H. J.; Marshall, R. T.; MacDonald, R. S. Antiproliferative effects of yogurt fractions obtained by membrane dialysis on cultured mammalian intestinal cells J. Dairy Sci. 1997, 80, 2325-2329
25. van Boekel, M. A.; Weerens, C. N.; Holstra, A.; Scheidtweiler, C. E.; Alink, G. M. Antimutagenic effects of casein and its digestion products Food Chem. Toxicol. 1993, 31, 731-737
26. McIntosh, G. H.; Regester, G. O.; Le Leu, R. K.; Royle, P. J.; Smithers, G. W. Dairy proteins protect against dimethylhydrazine-induced intestinal cancers in rats J. Nutr. 1995, 125, 809-816
27. Biffi, A.; Coradini, D.; Larsen, R.; Riva, L.; Di Fronzo, G. Antiproliferative effect of fermented milk on the growth of a human breast cancer cell line Nutr. Cancer 1997, 28, 93-99
28. Berger, Y.; Chapuis Bernasconi, C.; Neier, R.; Juillerat-Jeanneret, L. Determination of intracellular prolyl/glycyl-specific proteases in intact living human cells using protoporphyrin IX production as a reporter system Chem. Biol. 2005, 12, 867-872
29. Gotou, T.; Shinoda, T.; Mitzuno, S.; Yamamoto, N. Purification and identification of proteolytic enzymes from Aspergillus oryzae capable of producing the antihypertensive peptide Ile-Pro-Pro from β-casein J. Biosci. Bioeng. 2009, 107, 615-619
30. Corpet, D. E.; Yin, Y.; Zhang, X. M.; Remesy, C.; Stamp, D.; Medline, A.; Thompson, L.; Bruce, W. R.; Archer, M. C. Colonic protein fermentation and promotion of colon carcinogenesis by thermolyzed casein Nutr. Cancer 1995, 23, 271-281
31. Yamamoto, N.; Akino, A.; Takano, T. Antihypertensive effect of the peptides derived from casein by an extracellular proteinase from Lactobacillus helveticus CP790 J. Dairy Sci. 1994, 77, 917-922
32. Meisel, H. ACE-inhibitory activities in milk products Milchwissenschaft 1997, 52, 307-311
33. Pihlanto, L. A.; Rokka, T.; Korhonen, H. Angiotensin I converting enzyme inhibitory peptides derived from bovine milk proteins Int. Dairy J. 1998, 8, 325-331
34. Yamamoto, N.; Takano, T. Antihypertensive peptides derived from milk proteins Nahrung 1999, 43, 159-164
35. Shah, N. P. Effects of milk-derived bioactives: an overview Br. J. Nutr. 2000, 84 (Suppl. 1) S3-S10
36. Clare, D. A.; Swaisgood, H. E. Bioactive milk peptides: a prospectus J. Dairy Sci. 2000, 83, 1187-1195
37. Karaki, H.; Doi, K.; Sugano, S.; Uchiwa, H.; Sugai, R.; Murakami, U.; Takemoto, S. Antihypertensive effects of tryptic hydrolysate of milk casein in spontaneously hypertensive rats Comp. Biochem. Physiol. C 1990, 96, 367-371
38. Townsend, R. R.; McFadden, C. B.; Ford, V.; Cadée, J. A. A randomized, double-blind, placebo-controlled trial of casein protein hydrolysate (C12 peptide) in human essential hypertension Am. J. Hypertens. 2004, 17, 1056-1058
39. Roeb, E.; Dietrich, C. G.; Winograd, R.; Arndt, M.; Breuer, B.; Fass, J.; Schumpelik, V.; Matern, S. Activity and cellular origin of gelatinases in patients with colon and rectal carcinoma. Differential activity of matrix metalloproteinase-9 Cancer 2001, 92, 2680-2691
40. Stepniak, D.; Spaenij-Dakking, L.; Mitea, C.; Moester, M.; de Ru, A.; Baak-Pablo, R.; van Veelen, P.; Edens, L.; Koning, F. Highly efficient gluten degradation with a newly identified prolyl endopeptidase: implications for coeliac disease Am. J. Physiol. 2006, 291, G621-G629
41. Lovshin, J.; Drucker, D. J. New frontiers in the biology of GLP-2 Regul. Peptides 2000, 90, 27-32
42. Bouras, M.; Huneau, J. F.; Tomé, D. The inhibition of intestinal dipeptidyl peptidase-IV promotes the adsorption of enterostatin and des-arginine-enterostatin across rat jejunum in vitro Life Sci. 1996, 25/26, 2147-2155
43. Shan, L.; Molberg, O.; Parrot, I.; Hausch, F.; Filiz, F.; Gray, G. M.; Sollid, L. M.; Khosla, C. Structural basis for gluten intolerance in celiac sprue Science 2002, 297, 2275-2279
44. Hausch, F.; Shan, L.; Santiago, N. A.; Gray, G. M.; Khosla, C. Intestinal digestive resistance of immunodominant gliadin peptides Am. J. Physiol. 2002, 283, G996-G1003
45. Lankas, G. R.; Leiting, B.; Roy, R. S.; Eiermann, G. J.; Beconi, M. G.; Biftu, T.; Chan, C. C.; Edmonson, S.; Feeney, W. P.; He, H.; Ippolito, D. E.; Kim, D.; Lyons, K. A.; Ok, H. O.; Patel, R. A.; Petrov, A. N.; Pryor, K. A.; Qian, X.; Reigle, L.; Woods, A.; Wu, J. K.; Zaller, D.; Zhang, X.; Zhu, L.; Weber, A. E.; Thornberry, N. A. Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes. Potential importance of selectivity over dipeptidyl peptidases 8 and 9 Diabetes 2005, 54, 2988-2994
46. Lawandi, J.; Toumieux, S.; Seyer, V.; Thielges, S.; Juillerat-Jeanneret, L.; Moitessier, N. Computer-aided design, synthesis and biological evaluation of constrained prolyl oligopeptidase inhibitors. J. Med. Chem. 2009, 52, 6672 - 6684.
47. Saito, Y.; Ohura, S.; Kawato, A.; Suginami, K. Prolyl endopeptidase inhibitors in sake and its byproducts J. Agric. Food Chem. 1997, 45, 720-724
48. Asano, M.; Nio, N.; Ariyoshi, Y. Inhibition of prolyl endopeptidase by synthetic peptide fragments of human β-casein Agric. Biol. Chem. 1991, 55, 825-828 Ohura, S.; Kawato, A.; Suginami, K. Prolyl endopeptidase inhibitors in sake and its byproducts J. Agric. Food Chem. 1997, 45, 720-724
49. Asano, M.; Nio, N.; Ariyoshi, Y. Inhibition of prolyl endopeptidase by synthetic peptide frag